Haemonetics (HAE:NYSE) Investor Relations Material

Overview

Boston-based Haemonetics Corporation is a healthcare company that provides innovative medical products and solutions across the industry. The company operates through three main segments, namely Plasma, Blood Center, and Hospital, and offers a wide range of automated devices, related disposable products, and software to manage customers' donors, supply chain, and operations. Its product offerings include the NexSys PCS and PCS2 plasmapheresis equipment and intravenous solutions, as well as the NexLynk DMS donor management system. Furthermore, the company provides automated blood component and manual whole blood collection systems, including the MCS brand apheresis equipment, and disposable whole blood collection and component storage sets. Haemonetics also offers a suite of blood management and bedside transfusion solutions - the BloodTrack blood management software - which combines software with hardware components, as well as the SafeTrace Tx blood bank information system. The company's hospital products include a comprehensive range of hemostasis analyzer systems, such as TEG, ClotPro, and HAS, that give clinicians insight into a patient's overall hemostasis. Haemonetics also provides the TEG Manager software which connects various TEG analyzers throughout the hospital and provides remote access to active and historical test results to aid in decision making. Moreover, the company offers the Cell Saver Elite +, an autologous blood recovery system for surgeries related to cardiovascular, orthopedic, trauma, transplant, vascular, obstetrical, and gynecological surgeries. Haemonetics' products are marketed and sold through direct sales force, independent distributors, and sales representatives. The company was established in 1971 and prides itself on developing innovative solutions to meet the rapidly evolving healthcare industry's pressing demands.

Frequently Asked Questions

What is Haemonetics's ticker?

Haemonetics's ticker is HAE

What exchange is Haemonetics traded on?

The company's shares trade on the NYSE stock exchange

Where are Haemonetics's headquarters?

They are based in Braintree, Massachusetts

How many employees does Haemonetics have?

There are 1001-5000 employees working at Haemonetics

What is Haemonetics's website?

It is haemonetics.gcs-web.com

What type of sector is Haemonetics?

Haemonetics is in the Healthcare sector

What type of industry is Haemonetics?

Haemonetics is in the Medical Instruments & Supplies industry

Who are Haemonetics's peers and competitors?

The following five companies are Haemonetics's industry peers:

- Cantel Medical Corp.

- Antares Pharma Inc.

- Varex Imaging

- Predictive Oncology

- Teleflex